Preeclampsia Prediction Using Machine Learning and Polygenic Risk Scores From Clinical and Genetic Risk Factors in Early and Late Pregnancies
Top Cited Papers
- 1 February 2024
- journal article
- research article
- Published by Wolters Kluwer Health in Hypertension
- Vol. 81 (2) , 264-272
Abstract
BACKGROUND: Preeclampsia, a pregnancy-specific condition associated with new-onset hypertension after 20-weeks gestation, is a leading cause of maternal and neonatal morbidity and mortality. Predictive tools to understand which individuals are most at risk are needed. METHODS: We identified a cohort of N=1125 pregnant individuals who delivered between May 2015 and May 2022 at Mass General Brigham Hospitals with available electronic health record data and linked genetic data. Using clinical electronic health record data and systolic blood pressure polygenic risk scores derived from a large genome-wide association study, we developed machine learning (XGBoost) and logistic regression models to predict preeclampsia risk. RESULTS: Pregnant individuals with a systolic blood pressure polygenic risk score in the top quartile had higher blood pressures throughout pregnancy compared with patients within the lowest quartile systolic blood pressure polygenic risk score. In the first trimester, the most predictive model was XGBoost, with an area under the curve of 0.74. In late pregnancy, with data obtained up to the delivery admission, the best-performing model was XGBoost using clinical variables, which achieved an area under the curve of 0.91. Adding the systolic blood pressure polygenic risk score to the models did not improve the performance significantly based on De Long test comparing the area under the curve of models with and without the polygenic score. CONCLUSIONS: Integrating clinical factors into predictive models can inform personalized preeclampsia risk and achieve higher predictive power than the current practice. In the future, personalized tools can be implemented to identify high-risk patients for preventative therapies and timely intervention to improve adverse maternal and neonatal outcomes.Keywords
All Related Versions
This publication has 36 references indexed in Scilit:
- Gene-Centric Analysis of Preeclampsia Identifies Maternal Association at PLEKHG1Hypertension, 2018
- Aspirin for Evidence-Based Preeclampsia Prevention trial: effect of aspirin on length of stay in the neonatal intensive care unitAmerican Journal of Obstetrics and Gynecology, 2018
- The Biobank Portal for Partners Personalized Medicine: A Query Tool for Working with Consented Biobank Samples, Genotypes, and Phenotypes Using i2b2Journal of Personalized Medicine, 2016
- Competing risks model in screening for preeclampsia by maternal characteristics and medical historyAmerican Journal of Obstetrics and Gynecology, 2015
- A prospective study of maternal, fetal and neonatal deaths in low- and middle-income countriesBulletin of the World Health Organization, 2014
- Pre-eclampsia rates in the United States, 1980-2010: age-period-cohort analysisBMJ, 2013
- Clinical evaluation of a first trimester algorithm predicting the risk of hypertensive disease of pregnancyAustralian and New Zealand Journal of Obstetrics and Gynaecology, 2013
- Clinical risk prediction for pre-eclampsia in nulliparous women: development of model in international prospective cohortBMJ, 2011
- Prediction of the Development of Pregnancy-Induced Hypertensive Disorders in High-Risk Pregnant Women by Artificial Neural NetworksClinical Chemistry and Laboratory Medicine (CCLM), 2001
- Fetal and maternal contributions to risk of pre-eclampsia: population based studyBMJ, 1998